Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 12,500 shares of Parabilis Medicines stock in a transaction on Thursday, June 11th. The shares were bought at an average price of $20.00 per share, for a total transaction of $250,000.00. Following the completion of the purchase, the director directly owned 12,500 shares in the company, valued at $250,000. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Alan Sebulsky also recently made the following trade(s):
- On Monday, June 15th, Alan Sebulsky acquired 9,065 shares of Parabilis Medicines stock. The shares were bought at an average price of $26.49 per share, for a total transaction of $240,131.85.
- On Friday, June 12th, Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock. The shares were bought at an average price of $27.67 per share, for a total transaction of $233,396.45.
Parabilis Medicines Stock Up 6.3%
NASDAQ PBLS opened at $26.59 on Wednesday. Parabilis Medicines, Inc. has a 12 month low of $24.51 and a 12 month high of $34.47.
See Also
- Five stocks we like better than Parabilis Medicines
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
